Silencing Very-Low-Density Lipoprotein Receptor Reveals Alpha-1 Antitrypsin Role in HIV Infectivity

Area of Science:

• Virology
• Cell Biology
• Molecular Medicine

Background:

• Human immunodeficiency virus type 1 (HIV-1) entry into host cells is a complex process involving multiple cellular receptors.
• Alpha-1 antitrypsin (AAT) and very-low-density lipoprotein receptor (VLDLR) have been implicated in cellular processes, but their direct role in HIV-1 infection is not fully understood.

Purpose of the Study:

• To investigate the interaction between AAT and VLDLR in the context of HIV-1 virion internalization and infectivity.
• To elucidate the functional role of AAT and VLDLR in HIV-1 entry pathways.

Main Methods:

• Utilized silencing RNA (siRNA) to transiently inhibit VLDLR expression.
• Employed receptor-associated protein (RAP) to continuously block VLDLR activity.
• Investigated the effects of these manipulations on HIV-1 virion interaction, internalization, and infectivity.

Main Results:

• AAT was shown to participate with VLDLR during the internalization of both infectious and non-infectious HIV-1 virions.
• Transiently blocking VLDLR expression via siRNA and continuously blocking VLDLR activity with RAP demonstrated AAT's involvement in the process.
• These findings highlight a novel mechanism of HIV-1 entry facilitated by AAT and VLDLR.

Conclusions:

• AAT plays a significant role in HIV-1 virion internalization and subsequent infectivity by interacting with VLDLR.
• Targeting the AAT-VLDLR interaction could represent a potential therapeutic strategy to inhibit HIV-1 entry.